Dacia Kailin, PA
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,654 of the $3,001 with a category attached, or 88.4%. It is spread thinly across 13 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,522, 3.4 times the $441 reported in 2023. Among medical clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $30.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$551
- Arcutis Biotherapeutics, Inc.$549
- AbbVie$296
- E.r. Squibb & Sons, L.L.C.$287
- Lilly USA, LLC$261
- Incyte Corporation$254
- plus $802 from 7 others
What the payments were for
- Food & beverage$2,65488%
- Education$34712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 20 | $551 |
| Arcutis Biotherapeutics, Inc. | 16 | $549 |
| AbbVie | 14 | $296 |
| E.r. Squibb & Sons, L.L.C. | 8 | $287 |
| Lilly USA, LLC | 10 | $261 |
| Incyte Corporation | 7 | $254 |
| UCB, Inc. | 6 | $232 |
| Sanofi | 9 | $176 |
| Regeneron Healthcare Solutions, Inc. | 4 | $166 |
| Galderma Laboratories, L.p. | 3 | $94 |
| Sanofi-aventis U.S. LLC | 1 | $90 |
| Amgen | 1 | $29 |
| Organon | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,001 in reported general payments places this provider in the 90th percentile of 364 medical providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 56 | $4,785 |
| Fluorouracil | 51 | $3,729 |
| Tacrolimus | 24 | $2,476 |
| CiclopiroxCiclopirox Olamine | 76 | $1,724 |
| Triamcinolone Acetonide | 53 | $813 |
| Doxycycline Hyclate | 11 | $512 |
| Clindamycin Phosphate | 18 | $439 |
| Ketoconazole | 29 | $307 |
| Halobetasol Propionate | 12 | $268 |
| Nystatin | 13 | $192 |
| Finasteride | 24 | $169 |
| Mupirocin | 14 | $113 |
Paid to pharmacies, not to this prescriber.
Other medical in Bend
- Amy SnowBend$5K
- Katherine RajotteBend$2K
- Heidi HolmesBend$2K
- Mark DavisLake Oswego$12K
- Britt BennPortland$11K
- Benjamin WillettSalem$11K
- Jeffrey RennaSalem$9K
- Christy SnoSpringfield$8K
- Erica BallardPortland$8K
- Nicole WydraCorvallis$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.